# CAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI)

> **NCT05349201** · — · COMPLETED · sponsor: **Novartis Pharmaceuticals** · enrollment: 273 (actual)

## Conditions studied

- Diffuse Large B-Cell Lymphoma (DLBCL)
- Acute Lymphoblastic Leukemia (ALL)

## Interventions

- **OTHER:** KYMRIAH
- **OTHER:** YESCARTA

## Key facts

- **NCT ID:** NCT05349201
- **Lead sponsor:** Novartis Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-12-09
- **Primary completion:** 2021-05-28
- **Final completion:** 2021-05-28
- **Target enrollment:** 273 (ACTUAL)
- **Last updated:** 2022-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05349201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05349201, "CAR T Cells Real World Evidence Study Based on the French Hospital Claims Data Source (PMSI)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05349201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*